Bloomberg News

American Express, Amylin, EBay, Wynn: U.S. Equity Preview

October 20, 2011

Oct. 20 (Bloomberg) -- Shares of the following companies may have unusual moves in U.S. trading. Stock symbols are in parentheses.

American Express Co. (AXP US): The biggest credit-card issuer by purchases declined even after it said third-quarter profit climbed 13 percent, beating the average analyst projection, as customer spending increased and fewer borrowers defaulted.

Amylin Pharmaceuticals Inc. (AMLN US): The San Diego-based drugmaker had a third-quarter loss of 9 cents a share. Analysts projected a loss of 14 cents a share, on average, according to data compiled by Bloomberg.

Cubist Pharmaceuticals Inc. (CBST US): The Lexington, Massachusetts-based company that develops drugs to treat infections posted third-quarter earnings and sales that exceeded the average analyst projection and raised its annual revenue forecast.

EBay Inc. (EBAY US): The largest online marketplace forecast fourth-quarter sales and profit that missed some analysts’ estimates as it spends more on marketing products to woo developers and strengthen its payment services.

Kinder Morgan Energy Partners LP (KMP US): The company whose parent is buying El Paso Corp. said third-quarter profit fell and missed estimates on costs related to an acquisition in July.

SLM Corp. (SLM US): The student-loan maker known as Sallie Mae posted third-quarter results that exceeded analyst estimates after it increased loan originations and delinquency rates fell.

Stryker Corp. (SYK US): The Kalamazoo, Michigan-based maker of artificial hips and knees fell even after it boosted its 2011 earnings-per-share forecast after posting third-quarter profit that exceeded the average analyst projection.

Wynn Resorts Ltd. (WYNN US): The operator of the Wynn and Encore casinos reported third-quarter profit that missed analysts’ estimates as a recovery in Las Vegas slowed.

--Editor: Jeff Sutherland

To contact the reporter on this story: Whitney Kisling in New York at

To contact the editor responsible for this story: Nick Baker at

The Aging of Abercrombie & Fitch
blog comments powered by Disqus